Biosimilars India 2012

India 's biotechnology sector is the third largest in the Asia Pacific region, after Australia and China . The industry is now worth more that US$4 billion, growing from around US$3 billion in 2009, and tripling in size in the last 5 years alone.

Following two successful Biosimilars events in 2010 and 2011– Biosimilars India is now coming to Hyderabad !

With a 2-day strategic conference and post-conference workshop on Clinical Trials, Biosimilars India 2012 will bring together key stakeholders in the biopharmaceutical industry to learn about the latest industry developments and innovative commercialisation strategies that will propel your biosimilar strategies to the next level!